Screening for the early detection of cancer

Cancer Investigation

Volumn 4, Issue 3, 1986, Pages 225-238

  Prorok, Philip C ^a   Connor, Robert J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER SCREENING; COLORECTAL CANCER; DIAGNOSIS; FEMALE GENITAL SYSTEM; HUMAN; LARGE INTESTINE; LUNG CARCINOMA; PREVENTION; RESPIRATORY SYSTEM; UTERINE CERVIX CARCINOMA;

BREAST NEOPLASMS; CERVIX NEOPLASMS; CLINICAL TRIALS; COLONIC NEOPLASMS; EVALUATION STUDIES; FEMALE; HUMAN; LUNG NEOPLASMS; MASS SCREENING; NEOPLASMS; RANDOM ALLOCATION; RECTAL NEOPLASMS; RESEARCH DESIGN; TIME FACTORS;

EID: 0022528739     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357908609018453     Document Type: Article

References (81)

1. Screening for Disease
2. Controversy in the detection of disease
3. Summary and general recommendations
4. Comparison of a screening test and a reference test in epidemiologic studies: I. Indices of agreement and their relation to prevalence
5. Comparison of a screening test and a reference test in epidemiologic studies: II. A probabilistic model for the comparison of diagnostic tests
6. Some limitations and problems of screening for cancer
7. Basic issues in population screening for cancer
8. On the theory of screening for chronic diseases
9. The theory of periodic screening I: Lead time and proportion detected
10. The theory of periodic screening II: Doubly bounded recurrence times and mean lead time and detection probability estimation
11. A mathematical model used to analyze breast cancer screening strategies
12. An analysis of the benefits of serial screening for breast cancer based upon a mathematical model for the disease
13. Screening for the early detection of cancer-I: The temporal natural history of a progressive disease state
14. Screening for the early detection of cancer-II: The impact of screening on the natural history of the disease
15. When is screening effective in reducing the death rate
16. Detection of disease with periodic screening: Transient analysis and application to mammography examination
17. A simulation system for screening procedures
18. Predicting effects of mass screening for disease: A simulation approach
19. Evaluation of screening programs for the early detection of cancer
20. Theory of early detection of breast cancer in the general population
21. Mammography: a contrary view
22. Case definition in case-control studies of the efficacy of screening
23. Control definition in case-control studies of the efficacy of screening and diagnostic testing
24. General principles on evaluation of screening for cancer
25. Does screening by Pap smears help prevent cervical cancer? A case-control study
26. Use of case-control studies in evaluation of screening programs
27. The impact of vaginal cytology on cervical cancer risks in Cali, Columbia
28. Reduction of breast cancer mortality through mass screening with modern mammography
29. Evaluation of screening for breast cancer in a non-randomized study (the DOM project) by means of a case-control study
30. Randomized clinical trials: Perspectives on some recent ideas
31. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design
32. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, n. Analysis and examples
33. Looking backward: Is it worth the crick in the neck? Or: Pitfalls in using retrospective data
34. Acquiring new information while retaining old ethics
35. Validity of screening
36. Selection, follow-up, and analysis in the Health Insurance Plan study: A randomized trial with breast cancer screening
37. Report of the working group to review the NCI-ACS breast cancer detection demonstration projects
38. Periodic examination of patients at risk
39. Report of NCI ad hoc pathology working group to review the gross and microscopic findings of breast cancer cases in the HIP study
40. The effects of early treatment, lead time and length bias on the mortality experienced by cases detected by screening
41. Trends in the incidence of cervical cancer in the Nordic countries
42. Effect of cervical cancer screening in Scandinavia
43. Evaluation of screening programs for gynecological cancer
44. Pap smear and the risk of cervical neoplasia: Quantitative estimates from a case-control study
45. Guidelines for the cancer-related check-up: Recommendations and rationale
46. Cervical cancer screening programs: Summary of the 1982 Canadian task force report
47. Evaluating periodic multiphasic health check-ups: A controlled trial
48. Proctosigmoidoscopy and polypectomy in reducing the incidence of rectal cancer
49. The prevention of invasive cancer of the rectum
50. Value of periodic examinations in detecting cancer of the colon and rectum
51. Early detection of colorectal cancer with a modified guaiac test—A screening examination of 6,000 humans
52. Introduction: Screening approaches based on risk
53. Review of screening for colorectal cancer using fecal occult blood testing
54. Controlled trial of fecal occult blood tesing in the detection of colorectal cancer
55. Results of a screening program for early detection of colon cancer and polyps using fecal occult blood testing
56. Colon cancer control study: An interim report
57. A screening primer: Basic principles, criteria, and pitfalls of screening with comments on colorectal carcinoma
58. Occult-blood screening for colorectal carcinoma: The benefits
59. Occult blood screening for colorectal carcinoma: A critical review
60. Consensus conclusions and recommendations
61. Facts about colorectal cancer detection
62. Reduction in mortality from breast cancer after mass screening with mammography
63. The national study of breast cancer screening
64. Trial of early detection of breast cancer: Description of method
65. The Edinburgh randomized trial of screening for breast cancer: Description of method
66. Screening, detection and diagnosis of breast cancer
67. National Institutes of Health/National Cancer Institute Consensus Development Meeting on Breast Cancer Screening: Issues and Recommendations
68. Mammography 1982: A Statement of the American Cancer Society
69. Mammography Guidelines 1983: Background statement and update of cancer-related check-up guidelines for breast cancer detection in asymptomatic women age 40 to 49
70. Is curable lung cancer detected by semiannual screening
71. An evaluation of radiologic and cytologic screening for the early detection of lung cancer: A cooperative pilot study of the American Cancer Society and the Veterans Administration
72. South London lung cancer study
73. Earlier diagnosis and survival in lung cancer
74. Screening for lung cancer
75. Lung cancer mortality in males screened by chest X-ray and cytologic sputum examination: A preliminary report
76. Screening for early lung cancer, results of the Memorial Sloan-Kettering study in New York
77. Consensus conference on screening for lung cancer